EXACT SCIENCES CORPORATION

(EXAS)
  Report
Delayed Nasdaq  -  04:00 2022-08-17 pm EDT
39.56 USD   -3.77%
08/10TRANSCRIPT : Exact Sciences Corporation Presents at UBS Genomics 2.0 and Medtech Innovations Summit 2022, Aug-10-2022 01:00 PM
CI
08/04WALL STREET STOCK EXCHANGE : Still seeing the glass half full
MS
08/04ANALYST RECOMMENDATIONS : Illinois Tool Works, Eaton, Marathon Petroleum, Microchip Technology, DuPont de Nemours...
MS
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Exact Sciences Corporation(NasdaqCM:EXAS) added to Russell 2500 Value Index

06/24/2022 | 12:00am EDT

Exact Sciences Corporation(NasdaqCM:EXAS) added to Russell 2500 Value Index


© S&P Capital IQ 2022
All news about EXACT SCIENCES CORPORATION
08/10TRANSCRIPT : Exact Sciences Corporation Presents at UBS Genomics 2.0 and Medtech Innovatio..
CI
08/04WALL STREET STOCK EXCHANGE : Still seeing the glass half full
MS
08/04ANALYST RECOMMENDATIONS : Illinois Tool Works, Eaton, Marathon Petroleum, Microchip Techno..
MS
08/03Craig Hallum Lowers Exact Sciences Price Target to $60 From $81, Maintains Buy Rating
MT
08/03BTIG Adjusts Price Target on Exact Sciences to $70 From $100, Reiterates Buy Rating
MT
08/03Cowen Adjusts Price Target on Exact Sciences to $67 From $83, Keeps Outperform Rating
MT
08/03Baird Adjusts Price Target on Exact Sciences to $75 From $90, Keeps Outperform Rating
MT
08/03Raymond James Adjusts Price Target on Exact Sciences to $70 From $80, Keeps Outperform ..
MT
08/03Citigroup Adjusts Price Target on Exact Sciences to $50 From $65, Maintains Neutral Rat..
MT
08/03MDxHealth Agrees to Buy Exact Sciences' Prostate Cancer Unit for Up to $100 Million
MT
More news
Analyst Recommendations on EXACT SCIENCES CORPORATION
More recommendations
Financials (USD)
Sales 2022 2 013 M - -
Net income 2022 -757 M - -
Net Debt 2022 1 950 M - -
P/E ratio 2022 -9,31x
Yield 2022 -
Capitalization 7 001 M 7 001 M -
EV / Sales 2022 4,45x
EV / Sales 2023 3,97x
Nbr of Employees 6 460
Free-Float 99,1%
Chart EXACT SCIENCES CORPORATION
Duration : Period :
Exact Sciences Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EXACT SCIENCES CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 17
Last Close Price 39,56 $
Average target price 70,63 $
Spread / Average Target 78,5%
EPS Revisions
Managers and Directors
Kevin T. Conroy Chairman, President & Chief Executive Officer
Jeffrey Thomas Elliott Executive VP, Chief Operating & Financial Officer
Sandra Statz Senior VP-Clinical & Regulatory Affairs
Gary Frings Chief Information Officer
Paul J. Limburg Co-Chief Medical Officer
Sector and Competitors